Arash Mostaghimi, MD, MPH, FAAD: Assessing the Safety and Efficacy of Deuruxolitinib in Patients with Alopecia Areata

Dr. Mostaghimi discusses the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials that assessed the efficacy of deuruxolitinib in patients with alopecia areata.